Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 May;68(5):621–623. doi: 10.1136/adc.68.5.621

Sepsis and intravascular thrombosis.

R S Heyderman 1
PMCID: PMC1029328  PMID: 8323328

Full text

PDF
621

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angelini G. D., Cooper G. J., Lamarra M., Bryan A. J. Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass. Lancet. 1990 Mar 31;335(8692):799–800. doi: 10.1016/0140-6736(90)90922-r. [DOI] [PubMed] [Google Scholar]
  2. Bone R. C. Modulators of coagulation. A critical appraisal of their role in sepsis. Arch Intern Med. 1992 Jul;152(7):1381–1389. doi: 10.1001/archinte.152.7.1381. [DOI] [PubMed] [Google Scholar]
  3. Brandtzaeg P., Joø G. B., Brusletto B., Kierulf P. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res. 1990 Jan 15;57(2):271–278. doi: 10.1016/0049-3848(90)90326-8. [DOI] [PubMed] [Google Scholar]
  4. Colman R. W., Robboy S. J., Minna J. D. Disseminated intravascular coagulation (DIC): an approach. Am J Med. 1972 May;52(5):679–689. doi: 10.1016/0002-9343(72)90058-7. [DOI] [PubMed] [Google Scholar]
  5. Corrigan J. J., Jr, Ray W. L., May N. Changes in the blood coagulation system associated with septicemia. N Engl J Med. 1968 Oct 17;279(16):851–856. doi: 10.1056/NEJM196810172791603. [DOI] [PubMed] [Google Scholar]
  6. Ditter H., Matthias F. R., Voss R., Lohmann E. Beneficial effects of prostacyclin in a rabbit endotoxin shock model. Thromb Res. 1988 Aug 15;51(4):403–415. doi: 10.1016/0049-3848(88)90376-3. [DOI] [PubMed] [Google Scholar]
  7. FERGUSON J. H., CHAPMAN O. D. Fulminating meningococcic infections and the so-called Waterhouse-Friderichsen syndrome. Am J Pathol. 1948 Jul;24(4):763–795. [PMC free article] [PubMed] [Google Scholar]
  8. Fourrier F., Lestavel P., Chopin C., Marey A., Goudemand J., Rime A., Mangalaboyi J. Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates. Intensive Care Med. 1990;16(2):121–124. doi: 10.1007/BF02575306. [DOI] [PubMed] [Google Scholar]
  9. Gedde-Dahl T. W., Bjark P., Høiby E. A., Høst J. H., Bruun J. N. Severity of meningococcal disease: assessment by factors and scores and implications for patient management. Rev Infect Dis. 1990 Nov-Dec;12(6):973–992. doi: 10.1093/clinids/12.6.973. [DOI] [PubMed] [Google Scholar]
  10. Girardin E., Grau G. E., Dayer J. M., Roux-Lombard P., Lambert P. H. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med. 1988 Aug 18;319(7):397–400. doi: 10.1056/NEJM198808183190703. [DOI] [PubMed] [Google Scholar]
  11. Gérard P., Moriau M., Bachy A., Malvaux P., De Meyer R. Meningococcal purpura: report of 19 patients treated with heparin. J Pediatr. 1973 May;82(5):780–786. doi: 10.1016/s0022-3476(73)80066-6. [DOI] [PubMed] [Google Scholar]
  12. Heyderman R. S., Klein N. J., Shennan G. I., Levin M. Deficiency of prostacyclin production in meningococcal shock. Arch Dis Child. 1991 Nov;66(11):1296–1299. doi: 10.1136/adc.66.11.1296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Heyderman R. S., Klein N. J., Shennan G. I., Levin M. Reduction of the anticoagulant activity of glycosaminoglycans on the surface of the vascular endothelium by endotoxin and neutrophils: evaluation by an amidolytic assay. Thromb Res. 1992 Sep 15;67(6):677–685. doi: 10.1016/0049-3848(92)90071-h. [DOI] [PubMed] [Google Scholar]
  14. Jafari H. S., McCracken G. H., Jr Sepsis and septic shock: a review for clinicians. Pediatr Infect Dis J. 1992 Sep;11(9):739–748. doi: 10.1097/00006454-199209000-00014. [DOI] [PubMed] [Google Scholar]
  15. Klein N. J., Shennan G. I., Heyderman R. S., Levin M. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci. 1992 Aug;102(Pt 4):821–832. doi: 10.1242/jcs.102.4.821. [DOI] [PubMed] [Google Scholar]
  16. Lundsgaard-Hansen P., Doran J. E., Rubli E., Papp E., Morgenthaler J. J., Späth P. Purified fibronectin administration to patients with severe abdominal infections. A controlled clinical trial. Ann Surg. 1985 Dec;202(6):745–759. doi: 10.1097/00000658-198512000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lüscher E. F. Activated leukocytes and the hemostatic system. Rev Infect Dis. 1987 Sep-Oct;9 (Suppl 5):S546–S552. doi: 10.1093/clinids/9.supplement_5.s546. [DOI] [PubMed] [Google Scholar]
  18. MARGARETTEN W., McADAMS A. J. An appraisal of fulminant meningococcemia with reference to the Shartzman phenomenon. Am J Med. 1958 Dec;25(6):868–876. doi: 10.1016/0002-9343(58)90059-7. [DOI] [PubMed] [Google Scholar]
  19. McGehee W. G., Rapaport S. I., Hjort P. F. Intravascular coagulation in fulminant meningococcemia. Ann Intern Med. 1967 Aug;67(2):250–260. doi: 10.7326/0003-4819-67-2-250. [DOI] [PubMed] [Google Scholar]
  20. Nava E., Palmer R. M., Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet. 1991 Dec 21;338(8782-8783):1555–1557. doi: 10.1016/0140-6736(91)92375-c. [DOI] [PubMed] [Google Scholar]
  21. Renesto P., Kadiri C., Chignard M. Combined activation of platelets by cathepsin G and platelet activating factor, two neutrophil-derived agonists. Br J Haematol. 1992 Feb;80(2):205–213. doi: 10.1111/j.1365-2141.1992.tb08902.x. [DOI] [PubMed] [Google Scholar]
  22. Taylor F. B., Jr, Chang A., Ruf W., Morrissey J. H., Hinshaw L., Catlett R., Blick K., Edgington T. S. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 1991 Mar;33(3):127–134. [PubMed] [Google Scholar]
  23. Wachtfogel Y. T., Abrams W., Kucich U., Weinbaum G., Schapira M., Colman R. W. Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation. J Clin Invest. 1988 May;81(5):1310–1316. doi: 10.1172/JCI113456. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES